药物研究 SCIE

期刊简介预计审稿时间： 约3.0个月

Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to:

-(pre)formulation engineering and processing-

computational biopharmaceutics-

drug delivery and targeting-

molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)-

pharmacokinetics, pharmacodynamics and pharmacogenetics.

Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.

《制药研究》是美国制药科学家协会的官方期刊，致力于发表基于机制、以假设为驱动的新颖研究，解决药物发现、开发和监管方面的重要问题。当前感兴趣的领域包括但不限于：

-（预）配方工程和加工-

计算生物药剂学-

药物输送和靶向-

分子生物药剂学和药物处置（包括细胞和分子药理学）-

药代动力学、药效学和药物遗传学。

研究可能涉及非临床和临床研究，并采用体外和体内方法。欢迎研究小分子药物、药物固体材料（包括生物材料、聚合物和纳米颗粒）、生物技术产品（包括基因、肽、蛋白质和疫苗）和基因工程细胞。

《Pharmaceutical Research》(药物研究)编辑部通讯方式为SPRINGER/PLENUM PUBLISHERS, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。